Pacemakers Market Trends

Pacemakers Market Trends

The increasing prevalence of cardiovascular diseases is one of the major factors propelling the pacemakers industry gains and the adoption of cardiovascular devices. According to the World Health Organization, an estimated 17.9 million people died from CVDs in 2019, representing 32% of all global deaths. Of these deaths, 85% were due to heart attack and stroke. The increasing incidence & prevalence of cardiovascular conditions, such as congestive heart failure, arrhythmias, bradycardia, and tachycardia. As per the NCBI article, in 2023, ventricular tachycardia & fibrillation majorly accounts for sudden cardiac death with an estimated rate of 300,000 mortalities every year in the U.S. This accounts for around half of the mortalities associated with cardiac anomalies.
 

• The surge in these cardiac anomalies is set to drive the number of hospitalizations & medical procedures that in turn is projected to drive the adoption of pacemakers.
   
• According to the Institute for Health Metrics and Evaluation (IHME), the total prevalent cases of cardiovascular diseases surged exponentially from 271 million in 1990 to more than 520 million as of 2019. Also, the associated mortalities increased from 12.1 million in 1990, to 18.6 million in 2019.
   
• Moreover, the rising prevalence of cardiac diseases with increasing age further fuels the risk of congestive heart failure (CHF). As per the Cardiac Failure Review, heart failure is a rapidly growing public health issue with an estimated prevalence of 64 million people globally in 2024. The use of pacemakers in the management of CHF plays a major role in improving the heart's pumping ability and regulate its rhythm.